Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication May 24, 2019
- Accepted for publication August 30, 2019
- Published online April 1, 2020.
Article Versions
- previous version (October 18, 2019 - 10:07).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2020 by the Society of Nuclear Medicine and Molecular Imaging.
Author Information
- Ganna Blazhenets1,
- Yilong Ma2,
- Arnd Sörensen1,
- Florian Schiller1,
- Gerta Rücker3,
- David Eidelberg2,
- Lars Frings1,4 and
- Philipp T. Meyer1 for the Alzheimer Disease Neuroimaging Initiative
- 1Department of Nuclear Medicine, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
- 2Center for Neurosciences, Institute of Molecular Medicine, The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York
- 3Institute of Medical Biometry and Statistics, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; and
- 4Center for Geriatrics and Gerontology Freiburg, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
- For correspondence or reprints contact: Ganna Blazhenets, University of Freiburg Medical Center, Hugstetter Strasse 55, 79106, Freiburg, Germany. E-mail: ganna.blazhenets{at}uniklinik-freiburg.de
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
Related Articles
Cited By...
- Updated Appropriate Use Criteria for Amyloid and Tau PET: A Report from the Alzheimers Association and Society for Nuclear Medicine and Molecular Imaging Workgroup
- Principal-Component Analysis-Based Measures of PET Data Closely Reflect Neuropathologic Staging Schemes
- Validation of the Alzheimer Disease Dementia Conversion-Related Pattern as an ATN Biomarker of Neurodegeneration